Covid-19 Impact on Companion Diagnostic Technologies Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Companion Diagnostic Technologies, including the following market information:
Major competitors identified in this market include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher, etc.
Based on the Region:
- Global Companion Diagnostic Technologies Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Companion Diagnostic Technologies Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Companion Diagnostic Technologies Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Companion Diagnostic Technologies Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Immunohistochemistry
- Molecular Diagnostics
- Oncology
- Cardiovascular
- Central Nervous System
- Auto immune & Inflammation
- Virology
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Companion Diagnostic Technologies Industry
1.7 COVID-19 Impact: Companion Diagnostic Technologies Market Trends
2 GLOBAL COMPANION DIAGNOSTIC TECHNOLOGIES QUARTERLY MARKET SIZE ANALYSIS
2.1 Companion Diagnostic Technologies Business Impact Assessment - COVID-19
2.1.1 Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Companion Diagnostic Technologies Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Companion Diagnostic Technologies Quarterly Market Size, 2019 VS 2020
3.2 By Players, Companion Diagnostic Technologies Headquarters and Area Served
3.3 Date of Key Players Enter into Companion Diagnostic Technologies Market
3.4 Key Players Companion Diagnostic Technologies Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON COMPANION DIAGNOSTIC TECHNOLOGIES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Immunohistochemistry
1.4.2 Molecular Diagnostics
4.2 By Type, Global Companion Diagnostic Technologies Market Size, 2019-2021
5 IMPACT OF COVID-19 ON COMPANION DIAGNOSTIC TECHNOLOGIES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Cardiovascular
5.5.3 Central Nervous System
5.5.4 Auto immune & Inflammation
5.5.5 Virology
5.5.6 Others
5.2 By Application, Global Companion Diagnostic Technologies Market Size, 2019-2021
5.2.1 By Application, Global Companion Diagnostic Technologies Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Dako (Agilent Technologies)
7.1.1 Dako (Agilent Technologies) Business Overview
7.1.2 Dako (Agilent Technologies) Companion Diagnostic Technologies Quarterly Revenue, 2020
7.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Introduction
7.1.4 Dako (Agilent Technologies) Response to COVID-19 and Related Developments
7.2 Qiagen
7.2.1 Qiagen Business Overview
7.2.2 Qiagen Companion Diagnostic Technologies Quarterly Revenue, 2020
7.2.3 Qiagen Companion Diagnostic Technologies Product Introduction
7.2.4 Qiagen Response to COVID-19 and Related Developments
7.3 Roche
7.3.1 Roche Business Overview
7.3.2 Roche Companion Diagnostic Technologies Quarterly Revenue, 2020
7.3.3 Roche Companion Diagnostic Technologies Product Introduction
7.3.4 Roche Response to COVID-19 and Related Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Business Overview
7.4.2 Abbott Laboratories Companion Diagnostic Technologies Quarterly Revenue, 2020
7.4.3 Abbott Laboratories Companion Diagnostic Technologies Product Introduction
7.4.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Companion Diagnostic Technologies Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 bioMerieux
7.6.1 bioMerieux Business Overview
7.6.2 bioMerieux Companion Diagnostic Technologies Quarterly Revenue, 2020
7.6.3 bioMerieux Companion Diagnostic Technologies Product Introduction
7.6.4 bioMerieux Response to COVID-19 and Related Developments
7.7 Myriad Genetics
7.7.1 Myriad Genetics Business Overview
7.7.2 Myriad Genetics Companion Diagnostic Technologies Quarterly Revenue, 2020
7.7.3 Myriad Genetics Companion Diagnostic Technologies Product Introduction
7.7.4 Myriad Genetics Response to COVID-19 and Related Developments
7.8 Resonance Health Ltd.
7.8.1 Resonance Health Ltd. Business Overview
7.8.2 Resonance Health Ltd. Companion Diagnostic Technologies Quarterly Revenue, 2020
7.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Product Introduction
7.8.4 Resonance Health Ltd. Response to COVID-19 and Related Developments
7.9 Leica Microsystems
7.9.1 Leica Microsystems Business Overview
7.9.2 Leica Microsystems Companion Diagnostic Technologies Quarterly Revenue, 2020
7.9.3 Leica Microsystems Companion Diagnostic Technologies Product Introduction
7.9.4 Leica Microsystems Response to COVID-19 and Related Developments
7.10 Danaher
7.10.1 Danaher Business Overview
7.10.2 Danaher Companion Diagnostic Technologies Quarterly Revenue, 2020
7.10.3 Danaher Companion Diagnostic Technologies Product Introduction
7.10.4 Danaher Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Companion Diagnostic Technologies Industry
1.7 COVID-19 Impact: Companion Diagnostic Technologies Market Trends
2 GLOBAL COMPANION DIAGNOSTIC TECHNOLOGIES QUARTERLY MARKET SIZE ANALYSIS
2.1 Companion Diagnostic Technologies Business Impact Assessment - COVID-19
2.1.1 Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Companion Diagnostic Technologies Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Companion Diagnostic Technologies Quarterly Market Size, 2019 VS 2020
3.2 By Players, Companion Diagnostic Technologies Headquarters and Area Served
3.3 Date of Key Players Enter into Companion Diagnostic Technologies Market
3.4 Key Players Companion Diagnostic Technologies Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON COMPANION DIAGNOSTIC TECHNOLOGIES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Immunohistochemistry
1.4.2 Molecular Diagnostics
4.2 By Type, Global Companion Diagnostic Technologies Market Size, 2019-2021
5 IMPACT OF COVID-19 ON COMPANION DIAGNOSTIC TECHNOLOGIES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Cardiovascular
5.5.3 Central Nervous System
5.5.4 Auto immune & Inflammation
5.5.5 Virology
5.5.6 Others
5.2 By Application, Global Companion Diagnostic Technologies Market Size, 2019-2021
5.2.1 By Application, Global Companion Diagnostic Technologies Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Dako (Agilent Technologies)
7.1.1 Dako (Agilent Technologies) Business Overview
7.1.2 Dako (Agilent Technologies) Companion Diagnostic Technologies Quarterly Revenue, 2020
7.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Introduction
7.1.4 Dako (Agilent Technologies) Response to COVID-19 and Related Developments
7.2 Qiagen
7.2.1 Qiagen Business Overview
7.2.2 Qiagen Companion Diagnostic Technologies Quarterly Revenue, 2020
7.2.3 Qiagen Companion Diagnostic Technologies Product Introduction
7.2.4 Qiagen Response to COVID-19 and Related Developments
7.3 Roche
7.3.1 Roche Business Overview
7.3.2 Roche Companion Diagnostic Technologies Quarterly Revenue, 2020
7.3.3 Roche Companion Diagnostic Technologies Product Introduction
7.3.4 Roche Response to COVID-19 and Related Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Business Overview
7.4.2 Abbott Laboratories Companion Diagnostic Technologies Quarterly Revenue, 2020
7.4.3 Abbott Laboratories Companion Diagnostic Technologies Product Introduction
7.4.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Companion Diagnostic Technologies Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 bioMerieux
7.6.1 bioMerieux Business Overview
7.6.2 bioMerieux Companion Diagnostic Technologies Quarterly Revenue, 2020
7.6.3 bioMerieux Companion Diagnostic Technologies Product Introduction
7.6.4 bioMerieux Response to COVID-19 and Related Developments
7.7 Myriad Genetics
7.7.1 Myriad Genetics Business Overview
7.7.2 Myriad Genetics Companion Diagnostic Technologies Quarterly Revenue, 2020
7.7.3 Myriad Genetics Companion Diagnostic Technologies Product Introduction
7.7.4 Myriad Genetics Response to COVID-19 and Related Developments
7.8 Resonance Health Ltd.
7.8.1 Resonance Health Ltd. Business Overview
7.8.2 Resonance Health Ltd. Companion Diagnostic Technologies Quarterly Revenue, 2020
7.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Product Introduction
7.8.4 Resonance Health Ltd. Response to COVID-19 and Related Developments
7.9 Leica Microsystems
7.9.1 Leica Microsystems Business Overview
7.9.2 Leica Microsystems Companion Diagnostic Technologies Quarterly Revenue, 2020
7.9.3 Leica Microsystems Companion Diagnostic Technologies Product Introduction
7.9.4 Leica Microsystems Response to COVID-19 and Related Developments
7.10 Danaher
7.10.1 Danaher Business Overview
7.10.2 Danaher Companion Diagnostic Technologies Quarterly Revenue, 2020
7.10.3 Danaher Companion Diagnostic Technologies Product Introduction
7.10.4 Danaher Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Companion Diagnostic Technologies Assessment
Table 9. COVID-19 Impact: Companion Diagnostic Technologies Market Trends
Table 10. COVID-19 Impact Global Companion Diagnostic Technologies Market Size
Table 11. Global Companion Diagnostic Technologies Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Companion Diagnostic Technologies Market Growth Drivers
Table 14. Global Companion Diagnostic Technologies Market Restraints
Table 15. Global Companion Diagnostic Technologies Market Opportunities
Table 16. Global Companion Diagnostic Technologies Market Challenges
Table 17. By Players, Companion Diagnostic Technologies Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Companion Diagnostic Technologies Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Companion Diagnostic Technologies Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Companion Diagnostic Technologies Market
Table 21. Key Players Companion Diagnostic Technologies Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Companion Diagnostic Technologies Market Size 2019-2021, (US$ Million)
Table 24. Global Companion Diagnostic Technologies Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Companion Diagnostic Technologies Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 57. Dako (Agilent Technologies) Business Overview
Table 58. Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Dako (Agilent Technologies) Companion Diagnostic Technologies Product
Table 60. Dako (Agilent Technologies) Response to COVID-19 and Related Developments
Table 61. Qiagen Business Overview
Table 62. Qiagen Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Qiagen Companion Diagnostic Technologies Product
Table 64. Qiagen Response to COVID-19 and Related Developments
Table 65. Roche Business Overview
Table 66. Roche Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Roche Companion Diagnostic Technologies Product
Table 68. Roche Response to COVID-19 and Related Developments
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Abbott Laboratories Companion Diagnostic Technologies Product
Table 72. Abbott Laboratories Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Companion Diagnostic Technologies Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. bioMerieux Business Overview
Table 78. bioMerieux Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. bioMerieux Companion Diagnostic Technologies Product
Table 80. bioMerieux Response to COVID-19 and Related Developments
Table 81. Myriad Genetics Business Overview
Table 82. Myriad Genetics Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Myriad Genetics Companion Diagnostic Technologies Product
Table 84. Myriad Genetics Response to COVID-19 and Related Developments
Table 85. Resonance Health Ltd. Business Overview
Table 86. Resonance Health Ltd. Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Resonance Health Ltd. Companion Diagnostic Technologies Product
Table 88. Resonance Health Ltd. Response to COVID-19 and Related Developments
Table 89. Leica Microsystems Business Overview
Table 90. Leica Microsystems Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Leica Microsystems Companion Diagnostic Technologies Product
Table 92. Leica Microsystems Response to COVID-19 and Related Developments
Table 93. Danaher Business Overview
Table 94. Danaher Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Danaher Companion Diagnostic Technologies Product
Table 96. Danaher Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Companion Diagnostic Technologies Assessment
Table 9. COVID-19 Impact: Companion Diagnostic Technologies Market Trends
Table 10. COVID-19 Impact Global Companion Diagnostic Technologies Market Size
Table 11. Global Companion Diagnostic Technologies Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Companion Diagnostic Technologies Market Growth Drivers
Table 14. Global Companion Diagnostic Technologies Market Restraints
Table 15. Global Companion Diagnostic Technologies Market Opportunities
Table 16. Global Companion Diagnostic Technologies Market Challenges
Table 17. By Players, Companion Diagnostic Technologies Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Companion Diagnostic Technologies Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Companion Diagnostic Technologies Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Companion Diagnostic Technologies Market
Table 21. Key Players Companion Diagnostic Technologies Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Companion Diagnostic Technologies Market Size 2019-2021, (US$ Million)
Table 24. Global Companion Diagnostic Technologies Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Companion Diagnostic Technologies Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Companion Diagnostic Technologies Market Size, 2019-2021 (US$ Million)
Table 57. Dako (Agilent Technologies) Business Overview
Table 58. Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Dako (Agilent Technologies) Companion Diagnostic Technologies Product
Table 60. Dako (Agilent Technologies) Response to COVID-19 and Related Developments
Table 61. Qiagen Business Overview
Table 62. Qiagen Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Qiagen Companion Diagnostic Technologies Product
Table 64. Qiagen Response to COVID-19 and Related Developments
Table 65. Roche Business Overview
Table 66. Roche Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Roche Companion Diagnostic Technologies Product
Table 68. Roche Response to COVID-19 and Related Developments
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Abbott Laboratories Companion Diagnostic Technologies Product
Table 72. Abbott Laboratories Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Companion Diagnostic Technologies Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. bioMerieux Business Overview
Table 78. bioMerieux Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. bioMerieux Companion Diagnostic Technologies Product
Table 80. bioMerieux Response to COVID-19 and Related Developments
Table 81. Myriad Genetics Business Overview
Table 82. Myriad Genetics Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Myriad Genetics Companion Diagnostic Technologies Product
Table 84. Myriad Genetics Response to COVID-19 and Related Developments
Table 85. Resonance Health Ltd. Business Overview
Table 86. Resonance Health Ltd. Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Resonance Health Ltd. Companion Diagnostic Technologies Product
Table 88. Resonance Health Ltd. Response to COVID-19 and Related Developments
Table 89. Leica Microsystems Business Overview
Table 90. Leica Microsystems Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Leica Microsystems Companion Diagnostic Technologies Product
Table 92. Leica Microsystems Response to COVID-19 and Related Developments
Table 93. Danaher Business Overview
Table 94. Danaher Companion Diagnostic Technologies Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Danaher Companion Diagnostic Technologies Product
Table 96. Danaher Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Companion Diagnostic Technologies Product Picture
Figure 2. Companion Diagnostic Technologies Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Companion Diagnostic Technologies Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Companion Diagnostic Technologies Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Companion Diagnostic Technologies Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Companion Diagnostic Technologies Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Companion Diagnostic Technologies Market Size Market Share, 2019-2021
Figure 1. Companion Diagnostic Technologies Product Picture
Figure 2. Companion Diagnostic Technologies Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Companion Diagnostic Technologies Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Companion Diagnostic Technologies Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Companion Diagnostic Technologies Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Companion Diagnostic Technologies Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Companion Diagnostic Technologies Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Companion Diagnostic Technologies Market Size Market Share, 2019-2021
